Mflotas LP Eye Drop is a sterile, preservative-free ophthalmic solution indicated for the treatment of post-operative inflammation and pain following cataract surgery, as well as for the management of post-operative conjunctival erythema and pain following ocular surgery. The combination of loteprednol etabonate and moxifloxacin in Mflotas LP Eye Drop provides a dual mechanism of action, targeting both the inflammatory and antibacterial aspects of ocular disease. Loteprednol etabonate, a corticosteroid, reduces ocular inflammation and pain, while moxifloxacin, an antibacterial agent, inhibits the growth of a wide range of ocular pathogens. The 0.5% concentration of both components in Mflotas LP Eye Drop has been shown to be effective in reducing the signs and symptoms of ocular inflammation and infection, making it an effective treatment option for patients undergoing ocular surgery.